147 related articles for article (PubMed ID: 27713040)
1. Tetrahydrocurcumin in combination with deferiprone attenuates hypertension, vascular dysfunction, baroreflex dysfunction, and oxidative stress in iron-overloaded mice.
Sangartit W; Pakdeechote P; Kukongviriyapan V; Donpunha W; Shibahara S; Kukongviriyapan U
Vascul Pharmacol; 2016 Dec; 87():199-208. PubMed ID: 27713040
[TBL] [Abstract][Full Text] [Related]
2. Tetrahydrocurcumin protects against cadmium-induced hypertension, raised arterial stiffness and vascular remodeling in mice.
Sangartit W; Kukongviriyapan U; Donpunha W; Pakdeechote P; Kukongviriyapan V; Surawattanawan P; Greenwald SE
PLoS One; 2014; 9(12):e114908. PubMed ID: 25502771
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant and vascular protective effects of curcumin and tetrahydrocurcumin in rats with L-NAME-induced hypertension.
Nakmareong S; Kukongviriyapan U; Pakdeechote P; Donpunha W; Kukongviriyapan V; Kongyingyoes B; Sompamit K; Phisalaphong C
Naunyn Schmiedebergs Arch Pharmacol; 2011 May; 383(5):519-29. PubMed ID: 21448566
[TBL] [Abstract][Full Text] [Related]
4. Tetrahydrocurcumin alleviates hypertension, aortic stiffening and oxidative stress in rats with nitric oxide deficiency.
Nakmareong S; Kukongviriyapan U; Pakdeechote P; Kukongviriyapan V; Kongyingyoes B; Donpunha W; Prachaney P; Phisalaphong C
Hypertens Res; 2012 Apr; 35(4):418-25. PubMed ID: 22072109
[TBL] [Abstract][Full Text] [Related]
5. Effects of iron overload, an iron chelator and a T-Type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice.
Khamseekaew J; Kumfu S; Wongjaikam S; Kerdphoo S; Jaiwongkam T; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
Eur J Pharmacol; 2017 Mar; 799():118-127. PubMed ID: 28192097
[TBL] [Abstract][Full Text] [Related]
6. Meta-analytic review of the clinical effectiveness of oral deferiprone (L1).
Addis A; Loebstein R; Koren G; Einarson TR
Eur J Clin Pharmacol; 1999 Mar; 55(1):1-6. PubMed ID: 10206077
[TBL] [Abstract][Full Text] [Related]
7. A combination of an iron chelator with an antioxidant exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice.
Kumfu S; Khamseekaew J; Palee S; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
Free Radic Res; 2018 Jan; 52(1):70-79. PubMed ID: 29207893
[TBL] [Abstract][Full Text] [Related]
8. The oral iron chelator deferiprone protects against systemic iron overload-induced retinal degeneration in hepcidin knockout mice.
Song D; Zhao L; Li Y; Hadziahmetovic M; Song Y; Connelly J; Spino M; Dunaief JL
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4525-32. PubMed ID: 24970260
[TBL] [Abstract][Full Text] [Related]
9. The oral iron chelator deferiprone protects against iron overload-induced retinal degeneration.
Hadziahmetovic M; Song Y; Wolkow N; Iacovelli J; Grieco S; Lee J; Lyubarsky A; Pratico D; Connelly J; Spino M; Harris ZL; Dunaief JL
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):959-68. PubMed ID: 21051716
[TBL] [Abstract][Full Text] [Related]
10. Curcumin protects against cadmium-induced vascular dysfunction, hypertension and tissue cadmium accumulation in mice.
Kukongviriyapan U; Pannangpetch P; Kukongviriyapan V; Donpunha W; Sompamit K; Surawattanawan P
Nutrients; 2014 Mar; 6(3):1194-208. PubMed ID: 24662163
[TBL] [Abstract][Full Text] [Related]
11. Effect of Systemic Iron Overload and a Chelation Therapy in a Mouse Model of the Neurodegenerative Disease Hereditary Ferritinopathy.
Garringer HJ; Irimia JM; Li W; Goodwin CB; Richine B; Acton A; Chan RJ; Peacock M; Muhoberac BB; Ghetti B; Vidal R
PLoS One; 2016; 11(8):e0161341. PubMed ID: 27574973
[TBL] [Abstract][Full Text] [Related]
12. The influence of deferiprone (L1) and deferoxamine on iron and essential element tissue level and parameters of oxidative status in dietary iron-loaded mice.
Eybl V; Kotyzová D; Kolek M; Koutenský J; Nielsen P
Toxicol Lett; 2002 Mar; 128(1-3):169-75. PubMed ID: 11869827
[TBL] [Abstract][Full Text] [Related]
13. Effects of Iron Chelators on Pulmonary Iron Overload and Oxidative Stress in β-Thalassemic Mice.
Yatmark P; Morales NP; Chaisri U; Wichaiyo S; Hemstapat W; Srichairatanakool S; Svasti S; Fucharoen S
Pharmacology; 2015; 96(3-4):192-9. PubMed ID: 26316149
[TBL] [Abstract][Full Text] [Related]
14. Deferiprone inhibits iron overload-induced tissue factor bearing endothelial microparticle generation by inhibition oxidative stress induced mitochondrial injury, and apoptosis.
Chan S; Lian Q; Chen MP; Jiang D; Ho JTK; Cheung YF; Chan GC
Toxicol Appl Pharmacol; 2018 Jan; 338():148-158. PubMed ID: 29132816
[TBL] [Abstract][Full Text] [Related]
15. Activation of the molecular and functional effects of Nrf2 against chronic iron oxide nanorod overload-induced cardiotoxicity.
Elgharabawy RM; Elgharbawy DM; Emara AM
Hum Exp Toxicol; 2018 Aug; 37(8):870-885. PubMed ID: 29172713
[TBL] [Abstract][Full Text] [Related]
16. Effective new treatments of iron overload in thalassaemia using the ICOC combination therapy protocol of deferiprone (L1) and deferoxamine and of new chelating drugs.
Kontoghiorghes GJ; Kolnagou A
Haematologica; 2006 Jun; 91(6 Suppl):ELT04. PubMed ID: 16785141
[TBL] [Abstract][Full Text] [Related]
17. Asiatic acid reduces blood pressure by enhancing nitric oxide bioavailability with modulation of eNOS and p47phox expression in L-NAME-induced hypertensive rats.
Bunbupha S; Pakdeechote P; Kukongviriyapan U; Prachaney P; Kukongviriyapan V
Phytother Res; 2014 Oct; 28(10):1506-12. PubMed ID: 24723332
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.
Theodorakis NG; Wang YN; Korshunov VA; Maluccio MA; Skill NJ
World J Gastroenterol; 2015 Apr; 21(14):4126-35. PubMed ID: 25892862
[TBL] [Abstract][Full Text] [Related]
19. Chronic iron overload intensifies atherosclerosis in apolipoprotein E deficient mice: Role of oxidative stress and endothelial dysfunction.
Marques VB; Leal MAS; Mageski JGA; Fidelis HG; Nogueira BV; Vasquez EC; Meyrelles SDS; Simões MR; Dos Santos L
Life Sci; 2019 Sep; 233():116702. PubMed ID: 31356905
[TBL] [Abstract][Full Text] [Related]
20. Competition studies of L1-deferiprone with copper and iron. Possible implications on efficacy, toxicity and new therapeutic applications.
Pashalidis I; Kontoghiorghes GJ
Transfus Sci; 2000 Dec; 23(3):259-61. PubMed ID: 11099910
[No Abstract] [Full Text] [Related]
[Next] [New Search]
